Subjects must meet the following criteria for inclusion in the study:
Men ≥ 18 years of age
Multiparametric MRI within the previous 6 months
At least one lesion PI-RADS 3
Able to provide written informed consent
You may not be if
Previous prostate cancer diagnostic on MRI-targeted biopsy
At least one lesion PI-RADS 4-5
Negative MRI (PI-RADS 1-2)
Previous treatment for prostate cancer 11
Contraindication to PSMA PET and/or MRI and/or prostate biopsy
Low quality of MRI defined by a PI-QUAL score of 1 or 2
Any medical condition that may interfere with the study procedures.
Clareo Health | The Added-value of PSMA PET in Detecting Clinically Significant Prostate Cancer Lesions in Patients Undergoing MRI-targeted Biopsy. (PANDORA)
